Clinical Trial Update: Single Dose of Etomidate and Adrenal Cortex [Phase 4]

View source ↗

Summary

Phase 4 update on a single-dose etomidate protocol in patients with adrenal insufficiency and hemodynamic instability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenal Insufficiency
• Hemodynamic Instability

Drugs mentioned

• Etomidate (etomidate)

Snippet

Sponsor: Istanbul University | Conditions: Adrenocortical Deficiency, Hemodynamic Instability | Phase 4 | Status: COMPLETED